Phibro Animal Health (PAHC) Goodwill & Intangibles (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Goodwill & Intangibles of $91.6 million for Q1 2026, down 0.83% year-over-year from $92.3 million in Q1 2025, and down 1.41% quarter-over-quarter from $92.9 million in Q4 2025.
Phibro Animal Health (PAHC) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Phibro Animal Health's Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $91.6 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 0.83% year-over-year to $91.6 million; the TTM figure through Mar 2026 stood at $91.6 million (down 0.83% YoY), while the FY2025 annual figure was $96.1 million, down 3.49% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $91.6 million, down from $92.9 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $203.2 million in Q2 2023, with the low at $68.0 million in Q1 2022.
- The 5-year median for Goodwill & Intangibles is $99.6 million (2024), against an average of $105.8 million.
- The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles surged 73.59% in 2023, then slumped 51.0% in 2024.
- Phibro Animal Health's Goodwill & Intangibles stood at $112.3 million in 2022, then slipped by 5.92% to $105.6 million in 2023, then fell by 10.6% to $94.4 million in 2024, then decreased by 1.65% to $92.9 million in 2025, then fell by 1.41% to $91.6 million in 2026.
- Business Quant data shows PAHC's Goodwill & Intangibles at $91.6 million in Q1 2026, $92.9 million in Q4 2025, and $94.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.57 Mn |
| Dec 31, 2025 | 92.88 Mn |
| Sep 30, 2025 | 94.67 Mn |
| Jun 30, 2025 | 96.11 Mn |
| Mar 31, 2025 | 92.34 Mn |
| Dec 31, 2024 | 94.44 Mn |
| Sep 30, 2024 | 97.52 Mn |
| Jun 30, 2024 | 99.59 Mn |
| Mar 31, 2024 | 102.88 Mn |
| Dec 31, 2023 | 105.65 Mn |
| Sep 30, 2023 | 105.44 Mn |
| Jun 30, 2023 | 203.25 Mn |
| Mar 31, 2023 | 110.14 Mn |
| Dec 31, 2022 | 112.29 Mn |
| Sep 30, 2022 | 114.34 Mn |
| Jun 30, 2022 | 117.09 Mn |
| Mar 31, 2022 | 67.98 Mn |
| Dec 31, 2021 | 110.65 Mn |
| Sep 30, 2021 | 112.80 Mn |
| Jun 30, 2021 | 114.96 Mn |